“The legislation would delink PBM fees from the drug prices under Medicare Part D. This will help curb preferences for higher prices medications. I look forward to working with the Chairman in the coming weeks to build on this foundation by preventing prescription drug plans from charging patients based on sticker prices for certain medications. even as these same plans take in deep discounts.